PMC:7600245 / 38712-38794 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T141","span":{"begin":2,"end":18},"obj":"Disease"},{"id":"T142","span":{"begin":11,"end":18},"obj":"Disease"}],"attributes":[{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"},{"id":"A142","pred":"mondo_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/MONDO_0005170"}],"text":"d multiple myeloma. Selinexor is an orally bioavailable, selective inhibitor of ch"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T589","span":{"begin":67,"end":76},"obj":"Chemical"}],"attributes":[{"id":"A589","pred":"chebi_id","subj":"T589","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"d multiple myeloma. Selinexor is an orally bioavailable, selective inhibitor of ch"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T18","span":{"begin":2,"end":18},"obj":"Phenotype"}],"attributes":[{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0006775"}],"text":"d multiple myeloma. Selinexor is an orally bioavailable, selective inhibitor of ch"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1178","span":{"begin":2,"end":18},"obj":"Disease"}],"attributes":[{"id":"A1178","pred":"tao:has_database_id","subj":"1178","obj":"MESH:D009101"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"d multiple myeloma. Selinexor is an orally bioavailable, selective inhibitor of ch"}